As you all know, I bring up the idea of insiders buying

New Post Public Reply Private Reply Replies (0) Message Board
docj
326
As you all know, I bring up the idea of insiders buying shares on the open market. I have also posted links on how this can be done legally as part of a defined benefit package here and to Generex/NGIO. Yet here we sit for months(even years now) on end and no shares get purchased. With the frustration of CYDYers running high, some have asked the same question. Here is an exchange between a shareholder and the CYDY attorney:

Posted On: 05/18/2021 12:26:51 PM

Posted By: daemon57
Re: Bw #90738
I emailed Arian last night regarding this:

"
Question: Why aren't insiders purchasing with their own money? This would not only stabilize the stock price but would speak volumes for LONG shareholders morality (pretty much the BASE for CYDY).

Thank you. I hope we can recover from this FDA bullshit nonsense they posted....

daemon
"

This is what she replied:

"
Cydy Team
4:22 AM (8 hours ago)
to me

I would be Mr. XXXX and have in the past but we are in a closed window. Because we are not yet revenue producing we only have 3 windows a year for about 1 month each when we can trade in our stock and now the window is closed until 2 weeks in early August and then not until October."

Hope this helps bring clarification. Lets see how they act in August.

GLTU/A.


Read More: https://investorshangout.com/post/view?id=613...z6vEldYdoN



Dear Generex and Anthony Crisci, Esq.,

Please provide shareholders with confirmation if GNBT/NGIO has a benefit plan allowing insiders to purchase shares on the open market and the details involved regarding restrictions of such a plan.

Mr Crisci, I included you on this note as I have reached out to you several times and have never received a response.Are you forbidden by Generex to communicate with shareholders or do my emails seem to be of such little importance to respond?

Regards,

docj



1

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Jushi Holdings Inc. Prepares for Upcoming Financial Results Call

Updated Category News Views 84

Jushi Holdings Inc. to Announce Financial Results BOCA RATON, Fla. -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a well-established player in the cannabis industry, is gearing up to share its financial performance for the second quarter. This key announcement will take place after market hours on the fifth day of August. Details for...

Continue Reading
Mike Tyson Partners with BoltBetz to Innovate Cashless Gaming

Updated Category News Views 258

Mike Tyson's Exciting Role with BoltBetz BoltBetz, known for revolutionizing cashless gaming technology, has recently announced a significant partnership with the legendary boxing champion Mike Tyson. With Tyson as both a strategic investor and promotional partner, this collaboration promises to transform the landscape of gaming across various casinos. Tyson's entry into...

Continue Reading
Portage Community Bank Welcomes C. Joseph Assid as CFO

Updated Category News Views 233

Portage Community Bank Appoints New Executive Leader Portage Community Bank is thrilled to announce the appointment of C. Joseph Assid as the new Executive Vice President and Chief Financial Officer. With a rich experience spanning over twenty-five years in financial institution accounting, audit, and assurance services, Mr. Assid brings invaluable expertise to this...

Continue Reading
Angelalign Faces Patent Battle with Align in China

Updated Category News Views 7

Angelalign Technology Inc., listed as 6699.HK on the Hong Kong Stock Exchange, is heading back to court—this time, challenging a ruling from the Jinan Intermediate People's Court in China. They aim to overturn a judgment that ordered their subsidiaries to stop using key systems like the masterForce biomechanics simulation and the ATreat digital diagnosis system for...

Continue Reading
Unicycive Therapeutics Investors Encouraged to Act Now

Updated Category News Views 90

Unicycive Therapeutics Investigated for Potential Claims Investors holding securities in Unicycive Therapeutics, Inc. are facing an important deadline for potential legal actions. The company, listed on NASDAQ as UNCY, has come under scrutiny, and it's essential for affected investors to understand their options moving forward. Who Should Be Concerned? If you acquired...

Continue Reading